Literature DB >> 3533949

The role of DNA damage in chemical carcinogenesis of aromatic amines.

H G Neumann.   

Abstract

Many findings support the notion that the generation of DNA adducts by aromatic amines is causally related to carcinogenesis. Adducts have been identified in most cases and representative examples are reviewed. However, extent and persistence of DNA adducts (DNA dose) does not correlate satisfactorily with the tumor response of different tissues. Distribution of DNA damage, repair, indirect and secondary DNA damage are discussed as possible explanations for the observed noncorrelations. In addition, however, it is proposed to pay attention to specific mechanisms such as receptor mediated cellular effects which are not related to the generation of electrophiles. The effects of trans-4-aminostilbene and 2-amino-fluorene derivatives on rat liver are compared. It is concluded that trans-4-acetylamino-stilbene is a strong liver tumor initiator but an incomplete liver carcinogen lacking tumor promoting properties, and that 2-acetylaminofluorene is a complete liver carcinogen with initiating and promoting properties.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533949     DOI: 10.1007/bf00404390

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  42 in total

1.  In vitro reaction of the carcinogen, N-hydroxy-2-naphthylamine, with DNA at the C-8 and N2 atoms of guanine and at the N6 atom of adenine.

Authors:  F F Kadlubar; L E Unruh; F A Beland; K M Straub; F E Evans
Journal:  Carcinogenesis       Date:  1980-02       Impact factor: 4.944

Review 2.  The metabolic activation of carcinogenic aromatic amines and amides.

Authors:  J A Miller; E C Miller
Journal:  Prog Exp Tumor Res       Date:  1969

3.  The role of partial hepatectomy and of promoters in the formation of tumors in non-target tissues of trans-4-acetylaminostilbene in rats.

Authors:  D Hilpert; W Romen; H G Neumann
Journal:  Carcinogenesis       Date:  1983-12       Impact factor: 4.944

4.  DNA binding and mutation spectra of the carcinogen N-2-aminofluorene in Escherichia coli. A correlation between the conformation of the premutagenic lesion and the mutation specificity.

Authors:  M Bichara; R P Fuchs
Journal:  J Mol Biol       Date:  1985-06-05       Impact factor: 5.469

5.  Identification of nucleic acid adducts from trans-4-acetylaminostilbene.

Authors:  R Franz; H R Schulten; H G Neumann
Journal:  Chem Biol Interact       Date:  1986-10-01       Impact factor: 5.192

6.  Identification of the persistently bound form of the carcinogen N-acetyl-2-aminofluorene to rat liver DNA in vivo.

Authors:  J G Westra; E Kriek; H Hittenhausen
Journal:  Chem Biol Interact       Date:  1976-10-02       Impact factor: 5.192

7.  Accumulation and elimination of macromolecular lesions in susceptible and non-susceptible rat tissues after repeated administration of trans-4-acetylaminostilbene.

Authors:  D Hilpert; H G Neumann
Journal:  Chem Biol Interact       Date:  1985-06       Impact factor: 5.192

8.  Syncarcinogenic effects on the initiation of rat liver tumors by trans-4-acetylaminostilbene and 2-acetylaminofluorene.

Authors:  J Kuchlbauer; W Romen; H G Neumann
Journal:  Carcinogenesis       Date:  1985-09       Impact factor: 4.944

9.  N-Acetoxy-acetylaminofluorene reacts preferentially with a control region of intracellular SV40 chromosome.

Authors:  P Beard; M Kaneko; P Cerutti
Journal:  Nature       Date:  1981-05-07       Impact factor: 49.962

10.  Use of 2-acetamidophenanthrene and 2-acetamidofluorene in investigations of mechanisms of hepatocarcinogenesis.

Authors:  J D Scribner; B Woodworth; G Koponen; E H Holmes
Journal:  Environ Health Perspect       Date:  1983-03       Impact factor: 9.031

View more
  9 in total

Review 1.  Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research.

Authors:  Yewei Liu; Ting Yin; Yuanbo Feng; Marlein Miranda Cona; Gang Huang; Jianjun Liu; Shaoli Song; Yansheng Jiang; Qian Xia; Johannes V Swinnen; Guy Bormans; Uwe Himmelreich; Raymond Oyen; Yicheng Ni
Journal:  Quant Imaging Med Surg       Date:  2015-10

2.  Biomonitoring of aromatic amines and alkylating agents by measuring hemoglobin adducts.

Authors:  H G Neumann
Journal:  Int Arch Occup Environ Health       Date:  1988       Impact factor: 3.015

3.  Vitamin C inhibited DNA adduct formation and arylamine N-acetyltransferase activity and gene expression in rat glial tumor cells.

Authors:  C F Hung; K H Lu
Journal:  Neurochem Res       Date:  2001-10       Impact factor: 3.996

4.  Tumors in rat kidney generated by initiation with trans-4-acetylaminostilbene and several promoting treatments.

Authors:  A Hoffmann; W Romen; H G Neumann
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 5.  Role of genotoxic and nongenotoxic effects in multistage carcinogenicity of aromatic amines.

Authors:  H G Neumann; R Hammerl; W Hillesheim; M Wildschütte
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

6.  Binding of aromatic amines to the rat hepatic Ah receptor in vitro and in vivo and to the 8S and 4S estrogen receptor of rat uterus and rat liver.

Authors:  P Cikryt; T Kaiser; M Göttlicher
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

7.  Defining in vivo dose-response curves for kidney DNA adduct formation of aristolochic acid I in rat, mouse and human by an in vitro and physiologically based kinetic modeling approach.

Authors:  Rozaini Abdullah; Sebastiaan Wesseling; Bert Spenkelink; Jochem Louisse; Ans Punt; Ivonne M C M Rietjens
Journal:  J Appl Toxicol       Date:  2020-07-07       Impact factor: 3.446

Review 8.  Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer.

Authors:  Wei-Chiao Chiu; Da-Liang Ou; Ching-Ting Tan
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

9.  Modelling foetal exposure to maternal smoking using hepatoblasts from pluripotent stem cells.

Authors:  Baltasar Lucendo-Villarin; Panagiotis Filis; Madeleine J Swortwood; Marilyn A Huestis; Jose Meseguer-Ripolles; Kate Cameron; John P Iredale; Peter J O'Shaughnessy; Paul A Fowler; David C Hay
Journal:  Arch Toxicol       Date:  2017-05-16       Impact factor: 5.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.